Intrinsic Edge Capital Management’s ScottsMiracle-Gro SMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,000
Closed -$3.04M 143
2026
Q1
$3.04M Buy
+50,000
New +$3.23M 0.5% 77
2024
Q2
Sell
-468,104
Closed -$34.9M 194
2024
Q1
$34.9M Buy
+468,104
New +$29.1M 2.73% 2
2023
Q2
Sell
-417,847
Closed -$29.1M 207
2023
Q1
$29.1M Buy
+417,847
New +$30.1M 2.93% 1
2021
Q4
Sell
-10,000
Closed -$1.46M 263
2021
Q3
$1.46M Buy
+10,000
New +$1.64M 0.1% 191
2021
Q2
Sell
-16,544
Closed -$4.05M 274
2021
Q1
$4.05M Sell
16,544
-15,000
-48% -$3.4M 0.28% 129
2020
Q4
$6.28M Buy
31,544
+5,000
+19% +$857K 0.47% 75
2020
Q3
$4.06M Sell
26,544
-30,500
-53% -$4.71M 0.27% 130
2020
Q2
$7.67M Sell
57,044
-176,914
-76% -$22.8M 0.71% 43
2020
Q1
$24M Buy
233,958
+146,758
+168% +$16.1M 3.17% 2
2019
Q4
$9.26M Buy
+87,200
New +$8.92M 1.16% 25
2019
Q2
Sell
-143,980
Closed -$11.3M 146
2019
Q1
$11.3M Buy
+143,980
New +$10.9M 1.92% 16

Other funds holding SMG

Intrinsic Edge Capital Management's SMG Position: Q2 2026 in Review

Intrinsic Edge Capital Management sold out of ScottsMiracle-Gro (SMG) in Q2 2026, closing a stake of 50,000 shares — an estimated $3.04M sold.

Intrinsic Edge Capital Management first reported a position in SMG in Q1 2019 and held it in 11 quarters. The position peaked at $34.9M in Q1 2024. 464 funds tracked by Wall St. Rank hold SMG as of Q2 2026.

  • Intrinsic Edge Capital Management reported no remaining ScottsMiracle-Gro position as of Q2 2026 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 50,000 ScottsMiracle-Gro shares in Q2 2026, an estimated $3.04M.
  • Intrinsic Edge Capital Management first reported a position in ScottsMiracle-Gro in Q1 2019 and held it in 11 quarters.
  • Intrinsic Edge Capital Management's ScottsMiracle-Gro position peaked at $34.9M in Q1 2024.
  • 464 funds tracked by Wall St. Rank held ScottsMiracle-Gro as of Q2 2026.

Based on Intrinsic Edge Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.